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Abstract 
External auditory canal, like other epithelialized surfaces is 
predisposed to malignancies such as Squamous cell 
carcinomas (SCC), melanomas and adenocarcinomas. In 
this background, malignancies like adenoid cystic 
carcinoma (ACC) are a rare occurrence and need to be 
thoroughly evaluated both locally and for distant 
extension. The malignancy needs to be 
addressed with an aggressive approach 
surgically with adequate marginal 
clearance. The role of radiation is 
debatable considering the outcomes in 
the limited data. Here we present the case 
of a 35-year-old female who came in with 
otalgia and otorrhea associated with a 
mass in the external auditory canal. After 
biopsy and imaging, a diagnosis of 
adenoid cystic carcinoma was made and 
the patient was managed accordingly. 
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Introduction 
External ear malignancies are an oddity 
with squamous cell carcinoma (SCC) 
being the most commonly seen 
malignancy.1 In this background, the 
incidence of adenoid cystic carcinoma 
(ACC) is worth mentioning. ACC has an 
inclination towards the oral cavity and the 
bordering structures, i.e. oropharynx, 
salivary glands and nasopharynx with less 
than 0.2% of cases seen in the external auditory canal 
(EAC).2,3 Because of limited amount of literature 
available, evidence-based management is not well 
defined.1 Here, we have endeavoured to put forth our 
experience and highlight the major steps of 
management of this rare entity. 
Case Report 
A 35-year-old lady with no co-morbids presented to the 
Ear Nose and Throat (ENT) clinic of Aga Khan University 
Hospital, Karachi on 26th July, 2019. She complained of 
right otalgia and episodic discharge for the past six weeks. 
The otorrhea was serous and clear. There was no 
symptom of hearing loss or vertigo. The past history was 
also unremarkable. On examination, her right ear was 
tender to touch and otoscopic examination revealed a 
firm and non-fluctuant swelling arising from the 
posterosuperior aspect of the EAC. It was placed in the 
outer one-third of the EAC with scant crusting of 
discharge. Microscopic examination of the ear was done 
and tissue was obtained by punch biopsy. This 
histopathology was reported as adenoid cystic 
carcinoma. 
A contrast enhanced Computed Tomography (CT) study 
of the temporal bone and neck was done. It showed a 
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Figure-1: A) A soft tissue density visible present along the posterior aspect of the external auditory canal 
without any erosion into the temporal bone. B) Nodal involvement. C) No signs of soft tissue anterior invasion 
into the parotid gland or nodal involvement.
Figure-2: A) Coronal view showing enhancing lesion in right external auditory canal arising from superior canal. 
B) Sagittal view showing soft tissue lesion partially obstructing the lumen of external auditory canal.
partly defined enhancing soft tissue density lesion in the 
lateral aspect of the EAC on the right side which 
measured 11 x 12 x 13 mm in antero-posterior, transverse 
and craniocaudal dimensions respectively (Figure-1 and 
2). There was no underlying infiltration into the mastoid 
part of the right temporal bone or extension anteriorly 
into the parotid gland. 
As the tumour was limited to the EAC and there was lack 
of bony erosion, the tumour was staged as T1 using 
University of Pittsburgh TNM staging for EAC carcinoma4. 
Right level II showed a 10 mm lymph node. The patient 
was planned for surgery. 
The patient underwent wide local excision of tumour with 
right supraomohyoid neck dissection (Level I, II and III) on 
31st July, 2019. Intra-operatively a right sided 1.5 x 1.5 cm 
mass involving the posterior wall of the EAC and 
extending to superior canal was encountered. It was 
starting from the cartilaginous canal and extending to the 
bony canal medially. The lesion was excised. The 
underlying periosteum over the bony canal was healthy. 
Frozen sections were sent intra-operatively from medial, 
lateral, superior and inferior edges after excision, which 
were all reported to be negative. 
Histologically, the primary specimen consisted of a grey-
white firm tumour measuring 1.5 x 1 x 1cm lesion grossly. 
On microscopic examination, the dermis and the 
subcutaneous adipose tissue were infiltrated by a 
neoplastic lesion composed of nodules and nests with 
frequent small cystic spaces and tubule formation 
(Figure-3A and B). These basaloid neoplastic cells had 
scant cytoplasm and round to oval uniform nuclei with 
fine chromatin, inconspicuous nucleoli and scattered 
mitotic figures. Lumina of the cystic spaces and tubules 
contained eosinophilic basement lamina like material 
(Figure-3C). Perineural invasion was also identified 
(Figure-3D). Skin ulceration and lymphovascular invasion 
were not identified. All 25 lymph nodes were negative for 
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Figure-3: A) Skin covered tissue exhibiting a neoplastic lesion involving the dermis and the subcutaneous adipose tissue. Arrow is pointing towards epidermis. B) Nodules and nests 
with frequent small cystic spaces and tubule formation. C) Tumour cells are basaloid and uniform. Eosinophilic basement lamina-like material is seen in the lumina (arrow). D) 
Perineural invasion (arrow).
tumour metastasis. Pathologically the tumour was staged 
as pT1, N0 with superior and inferior margins being the 
closest margins. Patient was discharged and advised for 
monthly follow-ups. The patient was last seen in March 
2020 at the clinic, she is disease free and doing well. 
Discussion 
The presentation of ACC in the EAC is usually of severe 
otalgia, so much so that sometimes needle biopsy can be 
difficult to perform.5 In our case the primary complaint was 
otalgia but not as severe as reported previously. We were 
able to take a punch biopsy under local anaesthesia in the 
clinic. Only 10-15% of the tumours of the ear are housed in 
the EAC with a major predominance of SCC.3 Other than 
SCC, differential diagnosis includes basal cell carcinoma, 
adenocarcinoma, ACC, melanomas and sarcomatous 
lesions of the external canal.1 Adenoid cystic carcinoma in 
the EAC is primarily a malignancy of the secretory tissue, 
the ceruminous glands in the external auditory canal.5 The 
origin of the tissue has been a source of controversy. 
The salivary gland analogue was explained by Billroth, 
where the lesion was referred to as cylindroma. It was 
categorised as a benign lesion in the salivary glands 
initially. The overall prevalence ranged from 4-15%.2 
Histologically, ACC was shown to have three variants of 
different prognostic implications in the salivary gland 
tumours i.e. tubular, cribriform and solid. Though, 
similarities have been observed between the two 
analogues including local tissue extension and perineural, 
one study found it to be 80%. A detailed account of the 
correlation between the variants with their prognosis has 
not been established for EAC.5 The location of ACC, on 
rare occasions was found in the EAC which has been 
reported to have a wide spectrum of invasion. 
The presentation of ACC is most commonly in the form of 
otalgia, otorrhea, hearing loss and a mass present in the 
external canal. This progresses to symptoms associated 
with invasion, both local and distant. These include 
extension into the surrounding tissue mainly intracranial, 
into the parotid gland and neck nodes to distant tissue 
like pulmonary metastasis.5-7 ACC is associated with early 
direct parotid extension even in stage 1 lesions.8 
After the usual presentation, a cytological assessment is 
warranted. On smear, tri-dimensional aggregates, 
arranged uniformly into nests are observed with a scant 
amount of cytoplasm and nuclei showing hyperchromatic 
uptake.5 ACC does not have a separate classification for 
tumours of EAC and therefore, we have used University of 
Pittsburgh TNM staging.4 
Management of ACC in the EAC is primarily based on 
surgeon's experience, as due to the limited number of 
cases and scarcity of literature, an evidence-based 
management guideline has not been established.1 
Surgical management is predicated primarily on the 
extent of disease varying from local resection to lateral 
and sub-total temporal bone resection (LTBR and STBR, 
respectively).9 In our case, local resection with margin 
clearance was opted with unilateral supraomohyoid neck 
dissection. In this study, as there was no extension into 
the parotid on imaging, parotidectomy was not done. 
Post-operatively, radiation can be considered as an 
adjuvant therapy depending on the staging of the lesion, 
but the outcome is difficult to anticipate. Despite the 
available limited data, post-op radiation therapy has not 
yielded favourable results with a 5-year survival decline of 
24%.9 Chemotherapy has been considered for salivary 
gland tumours. The analogue and the response 
associated with ACC has been poor; consequently, but no 
substantial evidence regarding usage for External canal 
ACCs was seen.10 The disease is associated with an overall 
5-year survival of 70% with staging and margin clearance 
being the most significant prognostic factors. The survival 
ranges from 85% for T1 to 30% for T4 illness. Margin 
clearance has been reported to show an improvement of 
35% in 5-year survival rates.9 
Conclusion 
ACC of the EAC is primarily a rare malignancy of 
ceruminous tissue with local extension involving the 
parotids, neck nodes and intracranial structures. A greater 
index of suspicion must be employed with emphasis on 
imaging, both for local and distant spread. Eradication of 
the lesion should be taken up as aggressively as possible. 
More studies are needed to establish a management 
guideline. 
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